Literature DB >> 15879346

HMG-CoA reductase inhibitors improve acute ischemic stroke outcome.

Majaz Moonis1, Kevin Kane, Ute Schwiderski, Bobby W Sandage, Marc Fisher.   

Abstract

BACKGROUND AND
PURPOSE: Statins reduce the risk of stroke recurrence, but the benefits of statins in improving outcome of acute stroke patients have not been well explored.
METHODS: We assessed potential effects of statins initiated before or within 4 weeks of stroke on 90-day outcome. Favorable outcomes were National Institutes of Health Stroke Scale (NIHSS) score < or =2 at 12 weeks and modified Rankin Scale (mRS) < or =2.
RESULTS: Before stroke, 129 patients were receiving statins, 123 initiated statins within 4 weeks, and 600 patients were not on statins. Multivariate logistic regression analysis demonstrated that poststroke statins were associated with a significant probability of a favorable outcome at 12 weeks [NIHSS (P=0.002; OR, 1.92; CI, 1.27 to 2.91) and mRS (P=0.033; OR, 1.57; CI, 1.04 to 2.38)], whereas prestroke statins demonstrated a trend toward significance.
CONCLUSIONS: These preliminary results suggest that statin use may improve outcome of acute ischemic stroke.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15879346     DOI: 10.1161/01.STR.0000165920.67784.58

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  35 in total

1.  Effect of previous statin therapy on severity and outcome in ischemic stroke patients: a population-based study.

Authors:  Corine Aboa-Eboulé; Christine Binquet; Agnès Jacquin; Marie Hervieu; Claire Bonithon-Kopp; Jérôme Durier; Maurice Giroud; Yannick Béjot
Journal:  J Neurol       Date:  2012-06-24       Impact factor: 4.849

Review 2.  Statins and ischemic stroke severity: cytoprotection.

Authors:  Larry B Goldstein
Journal:  Curr Atheroscler Rep       Date:  2009-07       Impact factor: 5.113

3.  Statin therapy does not affect the radiographic and clinical profile of patients with TIA and minor stroke.

Authors:  N Asdaghi; J I Coulter; J Modi; M C Camden; A Qazi; M Goyal; T Rundek; S B Coutts
Journal:  AJNR Am J Neuroradiol       Date:  2015-04-23       Impact factor: 3.825

4.  Statin pretreatment is associated with better outcomes in large artery atherosclerotic stroke.

Authors:  Georgios Tsivgoulis; Aristeidis H Katsanos; Vijay K Sharma; Christos Krogias; Robert Mikulik; Konstantinos Vadikolias; Milija Mijajlovic; Apostolos Safouris; Christina Zompola; Simon Faissner; Viktor Weiss; Sotirios Giannopoulos; Spyros Vasdekis; Efstathios Boviatsis; Anne W Alexandrov; Konstantinos Voumvourakis; Andrei V Alexandrov
Journal:  Neurology       Date:  2016-02-24       Impact factor: 9.910

5.  Statins alone are ineffective in cerebral malaria but potentiate artesunate.

Authors:  Anne-Lise Bienvenu; Stéphane Picot
Journal:  Antimicrob Agents Chemother       Date:  2008-09-08       Impact factor: 5.191

6.  Neuroprotective effects of statins: evidence from preclinical and clinical studies.

Authors:  Marc Fisher; Majaz Moonis
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-06

7.  High-dose lovastatin for acute ischemic stroke: results of the phase I dose escalation neuroprotection with statin therapy for acute recovery trial (NeuSTART).

Authors:  Mitchell S V Elkind; Ralph L Sacco; Robert B Macarthur; Ellinor Peerschke; Greg Neils; Howard Andrews; Joshua Stillman; Tania Corporan; Dana Leifer; Rui Liu; Ken Cheung
Journal:  Cerebrovasc Dis       Date:  2009-07-16       Impact factor: 2.762

8.  Atorvastatin in stroke: a review of SPARCL and subgroup analysis.

Authors:  Branko N Huisa; Andrew B Stemer; Justin A Zivin
Journal:  Vasc Health Risk Manag       Date:  2010-04-15

9.  Statins and clinical outcome of acute ischemic stroke: a systematic review.

Authors:  Shaheen E Lakhan; Sanjit Bagchi; Magdalena Hofer
Journal:  Int Arch Med       Date:  2010-09-29

10.  Pretreatment with statins improves early outcome in patients with first-ever ischaemic stroke: a pleiotropic effect of statins or a beneficial effect of hypercholesterolemia?

Authors:  Adrià Arboix; Luis García-Eroles; Montserrat Oliveres; Cecília Targa; Miquel Balcells; Joan Massons
Journal:  BMC Neurol       Date:  2010-06-18       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.